Prelude Capital Management Portfolio holdings

Prelude Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Prelude Capital Management held 2,193 positions worth $3.36B, down 13% from $3.89B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Prelude Capital Management withdrew a net $561M in Q2 2021, closing 579 positions and reducing 430 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $39.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 6.6% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in KKR Acquisition Holdings I Corp. worth $36.3M.

• Prelude Capital Management's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 3,700,000 shares worth $36.3M.
• Prelude Capital Management added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $19.4M increase.
• Prelude Capital Management's biggest Q2 2021 reduction was Micron Technology, cutting an estimated $7.72M.
• Prelude Capital Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2021, selling an estimated $39.4M.
• Prelude Capital Management's ten largest holdings make up 31% of its $3.36B portfolio in Q2 2021.
• Prelude Capital Management opened 694 new positions and closed 579 in Q2 2021.
• Prelude Capital Management's portfolio value fell 13% quarter-over-quarter to $3.36B.

Based on Prelude Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.